Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
Authors
Keywords
-
Journal
Biomed Research International
Volume 2016, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2016-04-22
DOI
10.1155/2016/1752854
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013
- (2015) Gregory A. Roth et al. CIRCULATION
- Osteoprotegerin in Cardiometabolic Disorders
- (2015) C. Pérez de Ciriza et al. International Journal of Endocrinology
- Osteoprotegerin is up-regulated in pancreatic cancers and correlates with cancer-associated new-onset diabetes
- (2015) Wanchun Shi et al. BioScience Trends
- Elevated Osteoprotegerin Predicts Declining Renal Function in Elderly Women: A 10-Year Prospective Cohort Study
- (2014) Joshua R. Lewis et al. AMERICAN JOURNAL OF NEPHROLOGY
- Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation
- (2014) Paula Clancy et al. ATHEROSCLEROSIS
- Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification
- (2014) Carmen Pérez de Ciriza et al. CLINICAL BIOCHEMISTRY
- Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes
- (2014) Stella Bernardi et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model
- (2014) Veronica Tisato et al. PLoS One
- Tumor necrosis factor-related apoptosis-inducing ligand in vascular inflammation and atherosclerosis: A protector or culprit?
- (2014) Wen Cheng et al. VASCULAR PHARMACOLOGY
- Crosstalk between apoptosis, necrosis and autophagy
- (2013) Vassiliki Nikoletopoulou et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Osteoprotegerin Is an Independent Predictor of Vascular Events in Finnish Adults With Type 1 Diabetes
- (2013) D. Gordin et al. DIABETES CARE
- TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
- (2013) Belinda A. Di Bartolo et al. PLoS One
- The role of osteoprotegerin in cardiovascular disease
- (2012) Martina Montagnana et al. ANNALS OF MEDICINE
- TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
- (2012) S Jouan-Lanhouet et al. CELL DEATH AND DIFFERENTIATION
- TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammation
- (2012) Stella Bernardi et al. CLINICAL SCIENCE
- Osteoprotegerin, leptin and IL-6: Association with silent myocardial ischemia in type 2 diabetes mellitus
- (2012) Savas Guzel et al. Diabetes & Vascular Disease Research
- TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout mice
- (2012) Xiang Li et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
- (2012) Stella Bernardi et al. Recent Patents on Anti-Cancer Drug Discovery
- Osteoprotegerin promotes vascular fibrosis via a TGF-β1 autocrine loop
- (2011) Barbara Toffoli et al. ATHEROSCLEROSIS
- TRAIL attenuates the development of atherosclerosis in apolipoprotein E deficient mice
- (2011) Victoria Watt et al. ATHEROSCLEROSIS
- Crystallizing nanoparticles derived from vascular smooth muscle cells contain the calcification inhibitor osteoprotegerin
- (2011) Michael Schoppet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
- (2011) Henrik Reinhard et al. Cardiovascular Diabetology
- Osteoprotegerin Predicts Progression of Chronic Heart Failure: Results From CORONA
- (2011) Thor Ueland et al. Circulation-Heart Failure
- TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe −/− mice
- (2011) B. A. Di Bartolo et al. DIABETOLOGIA
- TRAIL shows potential cardioprotective activity
- (2011) Barbara Toffoli et al. INVESTIGATIONAL NEW DRUGS
- Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population: the Tromsø Study
- (2011) A. VIK et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Association of Osteoprotegerin With Aortic Stiffness in Patients With Symptomatic Peripheral Artery Disease and in Healthy Subjects
- (2010) M. Zagura et al. AMERICAN JOURNAL OF HYPERTENSION
- Biomarkers of the Osteoprotegerin Pathway
- (2010) Wolfgang Lieb et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction
- (2010) Paola Secchiero et al. ATHEROSCLEROSIS
- Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults
- (2010) Stefano Volpato et al. ATHEROSCLEROSIS
- Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse
- (2010) Merlin C. Thomas et al. CIRCULATION RESEARCH
- Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus
- (2010) Jong Suk Park et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Osteoprotegerin as a Predictor of Coronary Artery Disease and Cardiovascular Mortality and Morbidity
- (2010) Shreenidhi M. Venuraju et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease
- (2010) S. JONO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets
- (2010) Barbara Toffoli et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Inflammation, kidney function and albuminuria in the Framingham Offspring cohort
- (2010) Ashish Upadhyay et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients
- (2010) S. Liabeuf et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events
- (2009) Anne G. Semb et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction
- (2009) Paola Secchiero et al. ATHEROSCLEROSIS
- Prognostic value of apoptosis markers in advanced heart failure patients
- (2009) A. Niessner et al. EUROPEAN HEART JOURNAL
- Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo
- (2009) Riccardo Candido et al. JOURNAL OF VASCULAR RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Potential Prognostic Significance of Decreased Serum Levels of TRAIL after Acute Myocardial Infarction
- (2009) Paola Secchiero et al. PLoS One
- Osteoprotegerin released from the vascular wall by heparin mainly derives from vascular smooth muscle cells
- (2008) Mads Nybo et al. ATHEROSCLEROSIS
- Role of full-length osteoprotegerin in tumor cell biology
- (2008) G. Zauli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Osteoprotegerin Inhibits Vascular Calcification Without Affecting Atherosclerosis in ldlr (−/−) Mice
- (2008) Sean Morony et al. CIRCULATION
- Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy
- (2008) A. Jorsal et al. DIABETOLOGIA
- To kill a tumor cell: the potential of proapoptotic receptor agonists
- (2008) Avi Ashkenazi et al. JOURNAL OF CLINICAL INVESTIGATION
- Circulating Osteoprotegerin Levels and Long-Term Prognosis in Patients With Acute Coronary Syndromes
- (2008) Torbjørn Omland et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interaction between Angiotensin II, Osteoprotegerin, and Peroxisome Proliferator-Activated Receptor-γ in Abdominal Aortic Aneurysm
- (2008) Corey S. Moran et al. JOURNAL OF VASCULAR RESEARCH
- Expression, regulation and function of trail in atherosclerosis
- (2007) Mary M. Kavurma et al. BIOCHEMICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started